Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 4 , Pages 225-231 , August 2007

Findings Associated with Recurrence of Bacterial Vaginosis among Adolescents Attending Sexually Transmitted Diseases Clinics

  • Rebecca M. Brotman, MPH

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    • Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, Rockville, Maryland
    • Corresponding Author InformationAddress correspondence to: Rebecca M. Brotman, MPH, Johns Hopkins Bayview Medical Center, Infectious Diseases Division, 4940 Eastern Avenue, B-3 North, Baltimore, MD 21224
    • ,
  • Emily J. Erbelding, MD, MPH

      Affiliations

    • Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland
    • Baltimore City Health Department STD Program, Baltimore, Maryland
    • ,
  • Roxanne M. Jamshidi, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, Maryland
    • ,
  • Mark A. Klebanoff, MD, MPH

      Affiliations

    • Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, Rockville, Maryland
    • ,
  • Jonathan M. Zenilman, MD

      Affiliations

    • Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland
    • ,
  • Khalil G. Ghanem, MD

      Affiliations

    • Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland

References 

  1. Klebanoff SJ, Hillier SL, Eschenbach DA, et al. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis. 1991;164:94
  2. Pybus V, Onderdonk AB. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J Infect Dis. 1997;175:406
  3. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180:1863
  4. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36:663
  5. Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37:319
  6. Cohen CR, Duerr A, Pruithithada N, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS. 1995;9:1093
  7. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12:1699
  8. Cu-Uvin S, Hogan JW, Caliendo AM, et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis. 2001;33:894
  9. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162:585
  10. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19:185
  11. Koumans EH, Markowitz LE, Berman SM, et al. A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis. Int J Gynaecol Obstet. 1999;67(Suppl. 1):S29
  12. Ness RB, Hillier S, Richter HE, et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?. J Natl Med Assoc. 2003;95:201
  13. Beigi RH, Wiesenfeld HC, Hillier SL, et al. Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. J Infect Dis. 2005;191:924
  14. Schmid GP. The epidemiology of bacterial vaginosis. Int J Gynaecol Obstet. 1999;67(Suppl. 1):S17
  15. Marrazzo JM, Koutsky LA, Eschenbach DA, et al. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis. 2002;185:1307
  16. Schwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis. 1999;180:1632
  17. Tchamouroff SE, Panja SK. The association between receptive cunnilingus and bacterial vaginosis. Sex Transm Infect. 2000;76:144
  18. Hampton T. High prevalence of lesser-known STDs. JAMA. 2006;295:2467
  19. Shafer MA, Sweet RL. Pelvic inflammatory disease in adolescent females. Epidemiology, pathogenesis, diagnosis, treatment, and sequelae. Pediatr Clin North Am. 1989;36:513
  20. Bump RC, Buesching WJ. Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Gynecol. 1988;158:935
  21. Brabin L, Roberts SA, Fairbrother E, et al. Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics. Sex Transm Infect. 2005;81:483
  22. Tabrizi SN, Fairley CK, Bradshaw CS, et al. Prevalence of Gardnerella vaginalis and Atopobium vaginae in virginal women. Sex Transm Dis. 2006;33:663
  23. Ferris MJ, Masztal A, Martin DH. Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J Clin Microbiol. 2004;42:5892
  24. Ferris MJ, Masztal A, Aldridge KE, et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis. 2004;4:5
  25. Rodriguez JM, Collins MD, Sjoden B, et al. Characterization of a novel Atopobium isolate from the human vagina: description of Atopobium vaginae sp. nov. Int J Syst Bacteriol. 1999;49(Pt 4):1573
  26. Burton JP, Devillard E, Cadieux PA, et al. Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol. 2004;42:1829
  27. Verhelst R, Verstraelen H, Claeys G, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol. 2004;4:16
  28. Zhou X, Bent SJ, Schneider MG, et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology. 2004;150:2565
  29. Sobel JD. Vaginitis. N Engl J Med. 1997;337:1896
  30. Larsson PG. Treatment of bacterial vaginosis. Int J STD AIDS. 1992;3:239
  31. Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis. 1993;167:783
  32. Ivey JB. The adolescent with pelvic inflammatory disease: assessment and management. Nurse Pract. 1997;22:78
  33. Aral SO, Mosher WD, Cates W. Self-reported pelvic inflammatory disease in the United States, 1988. JAMA. 1991;266:2570
  34. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14
  35. Workowski KA, Berman SM. CDC sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2002;35:S135
  36. Sobel JD. What's new in bacterial vaginosis and trichomoniasis?. Infect Dis Clin North Am. 2005;19:387
  37. Yen S, Shafer MA, Moncada J, et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol. 2003;102:927
  38. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol. 2001;185:380
  39. Shoubnikova M, Hellberg D, Nilsson S, et al. Contraceptive use in women with bacterial vaginosis. Contraception. 1997;55:355
  40. Roy S. Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol. 1991;165:1240
  41. Calzolari E, Masciangelo R, Milite V, et al. Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet. 2000;70:341
  42. Korn AP, Bolan G, Padian N, et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol. 1995;85:387
  43. Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol. 2004;104:761
  44. Sweet RL, Mills J, Hadley KW, et al. Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol. 1979;134:68
  45. Bradshaw CS, Morton AN, Garland SM, et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol. 2005;106:105
  46. Ghanem KG, Hutton HE, Zenilman JM, et al. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect. 2005;81:421
  47. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996;174:1058
  48. Holzman C, Leventhal JM, Qiu H, et al. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health. 2001;91:1664
  49. Onderdonk AB, Delaney ML, Hinkson PL, et al. Quantitative and qualitative effects of douche preparations on vaginal microflora. Obstet Gynecol. 1992;80:333
  50. Ness RB, Hillier SL, Richter HE, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol. 2002;100:765
  51. Brotman R, Erbelding E, Colletta L, et al: Vaginal Douching: A Survey of Normative Beliefs in a STD Clinic Population. Presented at The International Society for Sexually Transmitted Disease Research, 15th Bi-Annual Congress, July 26–31, 2003, Ottawa, Canada
  52. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004;94:1327
  53. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect. 2004;80:8
  54. Wilson JD, Shann SM, Brady SK, et al. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS. 2005;16:736
  55. Andersch B, Lindell D, Dahlen I, et al. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecol Obstet Invest. 1990;30:114
  56. Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterial vaginosis with tinidazole. Obstet Gynecol. 2004;104:931
  57. Milani M, Barcellona E, Agnello A. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynecol Reprod Biol. 2003;109:67
  58. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283–1289

 This research was supported by National Institute of Allergy and Infectious Diseases grants T32 A1050056 (RMB), R03 A1061131 (JMZ), K24 A1001633 (JMZ), National Institute of Child Health and Human Development grant K23 HD047395 (KGG) and a NIH Intramural Research Training Award (RMB).

PII: S1083-3188(06)00342-1

doi: 10.1016/j.jpag.2006.11.009

Journal of Pediatric and Adolescent Gynecology
Volume 20, Issue 4 , Pages 225-231 , August 2007

Article Tools